BioCorteX
Company Details
Status: Private
Employees: 11-50
Location:
167-169 Great Portland Street, 5th Floor, London, W1W 5PF, GB
Type:
sample
sample
Technology:
sample
About: BioCorteX is a biotechnology company that utilizes artificial intelligence and computational modeling to enhance therapeutic development, particularly in the area of microbiome-host interactions. The company operates through two entities: Biocortex Ltd, established in the UK in 2021, and BIOCORTEX, INC., which opened in 2023. BioCorteX specializes in AI-driven platforms that aim to reduce risks in drug development and improve clinical trial outcomes.
The company offers several core services, including in silico clinical trials that simulate drug-bacteria-host interactions to predict clinical outcomes, microbiome analysis to assess how bacterial diversity affects drug efficacy, and therapeutic development support for various sectors such as pharmaceuticals and cosmetics. Their proprietary foundational emulator integrates microbiome data with AI to simulate human physiological responses to drugs, while their drug interaction models test numerous medications to identify success factors, particularly in antibody-drug conjugates for cancer therapy. BioCorteX targets pharmaceutical companies, biotech firms, and the cosmetics industry, providing insights to optimize product performance and safety.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BioCorteX | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.